NCT04734561

Brief Summary

The main objective of the present study is to observe the short-term effects of respiratory muscle training applied by telerehabilitation on quality of life and exercise tolerance in people who have had the COVID-19 disease. As secondary objectives, the effects on respiratory muscles strength/tolerance, pulmonary function and psychological and cognitive factors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 31, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 2, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

February 8, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2021

Completed
Last Updated

September 30, 2021

Status Verified

September 1, 2021

Enrollment Period

6 months

First QC Date

December 31, 2020

Last Update Submit

September 29, 2021

Conditions

Keywords

COVID-19Respiratory Muscle TrainingRespiratory Function TestQuality of LifePsychosocial Factor

Outcome Measures

Primary Outcomes (2)

  • Health-related quality of life

    To evaluate the health-related quality of life of the participants a valid, reliable and generic questionnaire will be used. It consisted of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension.

    Change from Baseline Health-related quality of life at 8 weeks

  • Exercise tolerance

    Exercise tolerance will be evaluated by a test consisted on 30 squats based on three different heart rate measuring moments (resting heart rate, heart rate after exercise, heart rate after longer period) evaluating the speed at which the heart rate increases/decreases.

    Change from Baseline Exercise tolerance at 8 weeks

Secondary Outcomes (7)

  • Maximum respiratory pressures

    Change from Baseline Maximum respiratory pressures at 8 weeks

  • Inspiratory muscle endurance

    Change from Baseline Inspiratory muscle endurance at 8 weeks

  • Upper limb muscle strength

    Change from Baseline Peripheral muscle strength at 8 weeks

  • Lung function (forced spirometry)

    Change from Baseline Lung function at 8 weeks

  • Cognitive factors

    Change from Baseline cognitive factors at 8 weeks

  • +2 more secondary outcomes

Study Arms (4)

Inspiratory muscle training group

EXPERIMENTAL

Participants will perform an inspiratory muscle training by a threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.

Other: Inspiratory muscle training group

Inspiratory muscle training placebo group

SHAM COMPARATOR

Participants will perform an inspiratory muscle training by a placebo threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.

Other: Inspiratory muscle training placebo group

Inspiratory + expiratory muscle training group

EXPERIMENTAL

Participants will perform an inspiratory and expiratory muscle training by a threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.

Other: Inspiratory + expiratory muscle training group

Inspiratory + expiratory muscle training placebo group

SHAM COMPARATOR

Participants will perform an inspiratory and expiratory muscle training by a placebo threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.

Other: Inspiratory + expiratory muscle training placebo group

Interventions

Participants will perform an inspiratory muscle training including warm-up, recovery between intervals and return to calm.

Inspiratory muscle training group

Participants will perform an inspiratory muscle training including warm-up, recovery between intervals and return to calm.

Inspiratory muscle training placebo group

Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.

Inspiratory + expiratory muscle training group

Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.

Inspiratory + expiratory muscle training placebo group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Positive diagnosis of COVID-19 (SARS-CoV2)
  • Hospital admission for COVID-19 in the last 3 months
  • Stable phase and home discharge;

You may not qualify if:

  • Severe cognitive impairment
  • Any type of musculoskeletal, neurological, cardiac or respiratory disease where training is contraindicated
  • Inability to carry out the training program through telematic supervision.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UComplutenseMadrid

Madrid, 28040, Spain

Location

Related Publications (5)

  • Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, Toresdahl BG, Rodeo SA, Casey EK, Mendias CL. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204. doi: 10.2106/JBJS.20.00847.

    PMID: 32675661BACKGROUND
  • Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31.

    PMID: 32475821BACKGROUND
  • Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society- and American Thoracic Society-coordinated international task force. Eur Respir J. 2020 Dec 3;56(6):2002197. doi: 10.1183/13993003.02197-2020. Print 2020 Dec.

    PMID: 32817258BACKGROUND
  • Jimenez-Pavon D, Carbonell-Baeza A, Lavie CJ. Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people. Prog Cardiovasc Dis. 2020 May-Jun;63(3):386-388. doi: 10.1016/j.pcad.2020.03.009. Epub 2020 Mar 24. No abstract available.

    PMID: 32220590BACKGROUND
  • Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract. 2020 May;39:101166. doi: 10.1016/j.ctcp.2020.101166. Epub 2020 Apr 1.

    PMID: 32379637BACKGROUND

MeSH Terms

Conditions

COVID-19

Interventions

Inhalation

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Respiratory MechanicsRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Ibai López de Uralde Villanueva, PhD

    Universidad Complutense de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: double-blind randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Ibai López de Uralde Villanueva

Study Record Dates

First Submitted

December 31, 2020

First Posted

February 2, 2021

Study Start

February 8, 2021

Primary Completion

July 31, 2021

Study Completion

September 29, 2021

Last Updated

September 30, 2021

Record last verified: 2021-09

Locations